111 Operating Income 2018-2024 | YI
111 Annual Operating Income (Millions of US $) |
|
---|---|
2024 | $0 |
2023 | $-49 |
2022 | $-54 |
2021 | $-101 |
2020 | $-73 |
2019 | $-71 |
2018 | $-58 |
2017 | $-38 |
111 Quarterly Operating Income (Millions of US $) |
|
---|---|
2024-12-31 | $-1 |
2024-09-30 | $0 |
2024-06-30 | $0 |
2024-03-31 | $1 |
2023-12-31 | $-29 |
2023-09-30 | $-11 |
2023-06-30 | $-6 |
2023-03-31 | $-3 |
2022-12-31 | $-14 |
2022-09-30 | $-11 |
2022-06-30 | $-12 |
2022-03-31 | $-16 |
2021-12-31 | $-18 |
2021-09-30 | $-27 |
2021-06-30 | $-29 |
2021-03-31 | $-26 |
2020-12-31 | $-25 |
2020-09-30 | $-18 |
2020-06-30 | $-13 |
2020-03-31 | $-16 |
2019-12-31 | $-24 |
2019-09-30 | $-17 |
2019-06-30 | $-15 |
2019-03-31 | $-16 |
2018-09-30 | $-19 |
2018-06-30 | |
2017-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.064B | $1.973B |
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $46.946B | 59.99 |
Hims & Hers Health (HIMS) | United States | $12.884B | 133.86 |
Tempus AI (TEM) | United States | $12.253B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.705B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.914B | 61.16 |
Privia Health (PRVA) | United States | $2.805B | 191.75 |
Hinge Health (HNGE) | United States | $2.743B | 0.00 |
Schrodinger (SDGR) | United States | $1.958B | 0.00 |
Enovis (ENOV) | United States | $1.904B | 10.62 |
Phreesia (PHR) | United States | $1.677B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
Omnicell (OMCL) | United States | $1.424B | 25.12 |
Azenta (AZTA) | United States | $1.410B | 65.55 |
10x Genomics (TXG) | United States | $1.327B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.661B | 0.00 |
Claritev (CTEV) | United States | $0.646B | 0.00 |
Butterfly Network (BFLY) | United States | $0.623B | 0.00 |
Talkspace (TALK) | United States | $0.518B | 154.75 |
Veradigm (MDRX) | United States | $0.476B | 0.00 |
Standard BioTools (LAB) | United States | $0.410B | 0.00 |
TruBridge (TBRG) | United States | $0.372B | 824.67 |
Outset Medical (OM) | United States | $0.362B | 0.00 |
Health Catalyst (HCAT) | United States | $0.276B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
Pulmonx (LUNG) | United States | $0.131B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
American Well (AMWL) | United States | $0.112B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
CareCloud (CCLD) | United States | $0.095B | 3.61 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.027B | 0.00 |
Zhongchao (ZCMD) | China | $0.026B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
Precipio (PRPO) | United States | $0.017B | 0.00 |
MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
Movano (MOVE) | United States | $0.006B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |